Portable ambulatory medical devices have proved useful for treating patients with medical conditions that require continuous monitoring and/or treatment. One example of such a portable ambulatory medical device is a device that involves the delivery of fluids. There are many applications in academic, industrial, and medical fields, as well as others, that involve devices capable of accurately and controllably delivering fluids, including liquids and gases, that have a beneficial effect when administered in known and controlled quantities. This is particularly true in the medical field, where treatments for many patients include the administration of a known amount of a substance at predetermined intervals. For example, the treatment of diabetes involves just such a regimented dosage of medicaments such as insulin. In addition, diabetes is one of a few medical indications wherein the patients routinely administer the medicament to themselves by a subcutaneous modality, such as a hypodermic syringe injection or by an ambulatory infusion pump. As such, providing a patient with the means to safely, reliably, and comfortably administer required doses of medication such as, e.g., insulin, may be particularly important in order to facilitate patient compliance and accurate treatment of the condition.
Ambulatory infusion pumps have been developed for the administration of medicaments such as insulin for those diagnosed with both type I and type II diabetes. These pumps offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. They also allow for continuous insulin therapy. In addition, some ambulatory infusion devices can include data collection and storage mechanisms, which allow a diabetic patient/user and/or a caregiver (e.g., doctor, health care worker, family member, and so forth) to easily monitor and adjust insulin intake. The infusion device may be powered by a rechargeable battery that requires periodic recharging.
Ambulatory medical devices may include a keypad, buttons, and/or touchscreen with a display on which symbols may be displayed and from which inputs may be received for operation of the device. A series of display screens or windows may be displayed on the touchscreen, showing alphanumeric text and symbols and providing menu screens through which the user can control operation of the device and receive information regarding the device and its operation, history, settings, interaction with the user, and the like. User interaction, such as by touching the alphanumeric text and symbols, provides user input and facilitates navigation through the menu screens and selection of the device functions.
With the advancement of medical devices and the increasing complexity of the user interfaces, some users may experience difficulty interacting with the user interface of the device, such as, for example, when entering inputs to operate the device. It is desirable to reduce the number of user errors and minimize the consequences of such errors. One difficulty users can experience, particularly when interacting with touch screen user interfaces, is the accidental touch of adjacent buttons/icons. A unique complication that may be present with respect to diabetic users for ambulatory insulin pumps is that these users may build up calluses on the tips of their fingers as a result of repeated blood glucose testing. Such calluses may be especially problematic for the operation of capacitive-based touch screen pump configurations. For example, calluses may prevent or hinder the transfer of energy that the capacitive screens use to receive input, thus preventing or hindering proper use of the touch screen to control the pump by the user.
To compensate for such difficulties in operation and provide improved user interface configurations, it is common in user interface research to observe and record the user inputs for performing a given task. One of the primary methods employed to aid this analysis is the use of external video cameras to record the user input over a period of time. The resulting data analysis can be tedious, as the analysis requires, e.g., comparison of the recorded touch sequence to an ideal task sequence. Any deviation from the expected task pathway may be noted as user error. Analysis of such deviations is then used as a design input to improve the accuracy of the human interface input.
Ambulatory infusion pumps with user interfaces implemented and incorporated therein enable the patient to administer the medicament, such as insulin, to themselves. For proper operation by a user of the device, it is important that the user be adequately trained with regard to the device operation. Some users, including patients and/or caregivers, may not be adept at operating such pumps, even if they are designed for simplicity and ease of use, and may require training to ensure proper operation of the device and efficacious treatment of their medical condition. Users, including patients and/or caregivers, may experience further complications with particular devices, such as insulin delivery systems, because each individual user responds uniquely to a given insulin dosage and rate of dosage. Such devices often require training so the patient does not over-medicate or under-medicate in myriad unique “real life” scenarios. Thus, with the rapid advancement and proliferation of such portable ambulatory medical devices, there is an associated need for increased training and clinician support.
Current trends in the delivery of health care are toward reduced patient medical support and, for operation of devices such as ambulatory medicament pumps, reduced training of users. This reduction is due in part to the overloading of health care resources such as hospitals, medical professionals, and caregivers, increasing financial limitations for access to medical care, rising healthcare costs, and a shortage of well-trained clinicians and caregivers.
In view of the discussion above, there is a need for systems and methods to more effectively train users, including patients and caregivers, for efficacious operation of ambulatory medical devices to accommodate each individual patient with unique circumstances and responses to therapy and to do so with reduced support from clinicians and others, including, e.g., representatives from the manufacturer of such ambulatory medical devices (such as field clinical support personnel, customer service representatives, certified diabetes educators (CDEs), sales representatives, etc.).
In view of the discussion above, there is also a need for systems and methods to improve the accuracy, efficiency and capability of the user interface system beyond the recording and play back analysis methods currently used in touch interface development.
Disclosed herein are devices, such as ambulatory portable medical devices (e.g., ambulatory pumps for the administration of insulin and other medicaments for the treatment of diabetes), and methods of improving the interaction of such devices with users. The portable device may include control features such as buttons or switches to control pumping and other factors, and the portable device may include a touch screen on which are displayed alphanumeric text, symbols, menu screens, data, alerts and other information. While in operation, the device provides features such that it receives user input and detects device parameter values at the time of the user input. The device writes the received user input and the device parameter values into memory of the device. The features may be provided in an operating mode of the device, or the features may be provided as a function or application within an operating mode of the device.
For example, the device may have one or more modes of operation including a training simulation mode, a normal operating mode, and an initial operating mode. The device may include a processor and system bus, and may also connect compatible external sensors to the system bus for gathering and storing device parameter data. In one embodiment, a normal operating mode of the device detects user interactions and records the interactions along with various device parameters at the time of the interaction, and allows a clinician to review the user's performance for the initial use period. Automated analysis software may operate to analyze the data generated by the user during the normal operating mode. The results of the analysis may be used by the clinician to improve the user and device interaction. This can be done by changing settings in the device, and/or providing additional training to the user.
Other features and advantages of the present invention should be apparent from the following description of preferred embodiments that illustrate, by way of example, the principles of the invention.
of the housing removed.
The drawings illustrate embodiments of the technology and are not limiting. For clarity and ease of illustration, the drawings may not be made to scale and, in some instances, various aspects may be shown exaggerated or enlarged to facilitate an understanding of particular embodiments.
Disclosed herein are embodiments directed to a portable medical device having an interactive display screen, such as a touchscreen, for control by the user, and having a connecting tube with an infusion port for administering medication to a patient.
The portable device 100 may be coupled to a patient 114 via an infusion port 116 and a connecting tube or cannula 118. The connecting tube is coupled to the portable device 100 at a fluid dispensing port 120. The portable device may include control features, such as buttons or switches 121 to receive user input and control pumping and other functions, and may include a display screen 122 on which messages and alerts are displayed. The display 122 may comprise, for example, a touchscreen on which user inputs may be received. A housing 124 of the portable device encloses internal components, such as fluid reservoirs, electrical components, battery, and the like. The portable device 100 illustrated in
The portable device 100 can be coupled to a host power source such as a desktop or laptop computer, through a cable connected to the connector port 110. The cable may comprise, for example, a coupling through which both data and electrical energy are received at the portable device 100. Examples of such combined power and data cables include a Universal Serial Bus (USB) connection, an IEEE 1499 (FireWire) connection, a “THUNDERBOLT” connection (from Apple, Inc. of Cupertino, Calif., USA), PCI Express, eSATA and Ethernet.
The device 100 may also include a capability to operatively couple to one or more other devices via a wired or wireless (e.g., infrared, electronic, optical, etc.) link, locally or via a network, such as, e.g., a portable or non-portable medical device, a control unit, external monitor or display, a personal, laptop, tablet or mainframe computer, or mobile communication device such as a smartphone or personal digital assistant (PDA). Such other devices may control or be controlled by device 100 and/or may otherwise communicate for the transfer of data including device parameters between or among device 100 and other device(s) for analysis of data (e.g., user data for physician review, device diagnostic data for troubleshooting or repair), programming, or other uses.
The portable device 100 may include control features such as buttons, panels, screens, and/or switches to control pumping and other functions, or any combination of such control features. For example, the portable device 100 illustrated in
Device parameters provided by the portable infusion device may be presented on the display screen 122 as any number of objects, including one or more numeric and/or alphanumeric values, a range, a value or range that is presented in the form of a drop-down menu, a toggle that can be adjusted by the user, a graphical representation (e.g., icon) or an animated graphic. For instance, in certain embodiments, the value is a range of values that are presented on a screen of the display as a toggle, wherein the toggle may be adjusted upwards or downwards by the user swiping a finger over the screen to select the appropriate value range, e.g. appropriate range of amounts of medicament such as insulin to be delivered and/or the appropriate rate, time, or interval of medicament delivery. In certain instances, the values presented in the range may be adjusted by the processor (illustrated in
If the device includes a touchscreen 122 as in
A control processor 218 is connected to the system bus 212 and receives the data communications from the connector data element 208 for processing. The control processor controls operation of the various elements of the portable device 100 that are connected to the system bus. The control processor operates according to mode instructions that may be stored in device memory 220.
During operation of the device according to typical usage, such as when the device provides the actions for which it is designed, the device provides features such that it receives user input and detects device parameter values at the time of the user input and writes the received user input and the device parameter values into memory of the device. In the case of a portable infusion pump, for example, the operational actions include pumping medicaments such as insulin to a patient. The parameter detecting and memory writing features of the device may be provided in an operating mode of the device, or they may be provided as a function or application within an operating mode of the device. The phrases “mode” and “function” may be used interchangeably, as required by context, as will be known to those skilled in the art.
The devices of
For example, the device may have a normal operating mode where the device is attached to the patient and the device is capable of receiving and responding to user interaction, and delivering medicament as required. The device may also have a training mode in which the device may or may not be coupled to the patient and the clinician can simulate scenarios on the device while monitoring the patient's interactions with the device. The parameter detecting and memory writing features of the device as described herein would not ordinarily be available in the training mode, absent a function that permits the device to operate so as to provide the actions (e.g., pumping) for which it is designed.
The parameter detecting and memory writing features may be provided autonomously by the device, without input from the user, or providing the parameter detecting and memory writing features may require specific input from the user. In the case of specific input from the user, the parameter detecting and memory writing features may be provided as a function of the normal operating mode, initiated through a special configuration by an authorized clinician or other suitable person and comprising a temporary modification to the normal operating mode. Alternatively, the parameter detecting and memory writing features can be initiated from the time of initial power-on of the device, and continuing on for a predetermined subsequent time, at which time the parameter detecting and memory writing features are terminated. Alternatively, the device may continually monitor patient performance, without termination of the parameter detecting and memory writing features, providing a mode of operation that facilitates review of user performance at the time of a call to customer service or other request for assistance. The device may also have a playback function, wherein a user, caregiver, clinician, or the like can review data stored in the device memory.
Program instructions may be stored in processor memory incorporated in the control processor 218. The control processor also stores data including device parameters, from its operations in the device memory 220. The control processor 218 controls a data communications element 222 that may comprise a receiver/transmitter for wireless RF communications, such as “WiFi” communications or “Bluetooth” communications between the portable device 100 and compatible external systems and networks. The communications may take place over proprietary networks or links, or may take place using secure links over public networks. The device 100 includes an output/display element 122 such as a touchscreen display, operating buttons or switches. The device 100 of
The device may also connect compatible external sensors to the system bus 212 for gathering and storing device parameter data. The device parameter data can be used as an input to the processor to make automated decisions, it can be reported to the user through the touchscreen 122 to aid the user in making self-medicating decisions, or it can be recorded into memory 220 for later analysis. The data may also be sent to a third party or another device for monitoring the patient's status. Other uses of such data are well known and are readily apparent to those skilled in the art. The external sensors can be any type of sensors useful for the operation of the device, such as optical, electrical, mechanical, electro-mechanical and chemical. The external sensors may be, e.g., traditional physical sensors that monitor body temperature, blood pressure, and the like, or they can be sensors that utilize chemical or biological reactions. Chemical and biological sensors differ from physical sensors, which are limited to the measurement of basic physical parameters. An exemplary and well-known chemical or biosensor is an enzyme electrode for the detection of glucose. These sensors are typically comprised of a bioactive surface consisting of immobilized glucose oxidase sandwiched between a polycarbonate and cellulose acetate membrane. The transducer is a platinum electrode and the output is typically a low current on the order of microamperes. Myriad chemical and biological sensors are available and are well known in the art such as Ph sensors for in vivo blood gasses, fiber-optic glucose sensors, biosensors based on transition metal hexcyanoferrates and chemically prepared grapheme-based nanomaterials.
The memory 220 of the device 100 may be any type of memory capable of storing data and retrieving that data for transfer to one or more other components of the device, such as the control processor 218. The memory may comprise one or more of a Flash memory, SRAM, ROM, DRAM, RAM, EPROM and dynamic storage. For the illustrated portable fluid delivery device 100 of
The memory can also be configured to store one or more personalized (e.g., user defined) delivery profiles, such as a profile based on a user's selection and/or grouping of various input parameters; past generated delivery profiles; recommended delivery profiles and one or more traditional delivery profiles, e.g., square wave, dual square wave, basal and bolus rate profiles. The memory can also store other device parameters such as user information, history of use, glucose measurements including blood glucose data and continuous glucose monitoring data, compliance and a calendar of events. An infusion workflow, or protocol, may be at least part of a program that displays a sequence of menu pages to assist a user to at least program or control the portable infusion device and/or at least one operation comprising input, change, confirm, or view various information within the device. Any part of a workflow or protocol may include any number of queries for prompting the user to enter, modify, or confirm information, which are typically presented to the user on the touchscreen display. In some embodiments, the memory 220 of the portable medical device 100 may have a data capacity of up to about 10 GB, more specifically, up to about 3 GB, even more specifically, about 1 MB to about 200 MB. In some embodiments, the memory of the infusion device 200 may be up to about 3 GB, more specifically, up to about 500 MB or more, and even more specifically, about 200 kB to about 200 MB. Larger memory sizes will permit more extensive use and operating modes, such as continual use in recording device parameters and/or user interactions, rather than initial use.
The device 100 comprises an infusion pump device, and therefore also includes a drive/pump element such as a pumping mechanism for delivery of fluid such as insulin to the connecting tube 118, as described above in connection with
In step 508 the stored data can be played back in a playback mode on the device itself, or the stored data can be transferred from device memory to a separate device, such as a computer, for playback. In step 510 the user interaction with the device can be analyzed for potential or actual errors. The analysis can be performed on a screen-by-screen basis or through analysis software that processes all the stored user interactions and provides an automatic summary of the patient's therapy. The analysis software may reside on an external device or may be installed at the device itself. The analysis operations of the software may be applied to stored or historical data. The analysis may be applied in real-time as the patient is operating the device, to provide an indication of how well the patient is operating the device. The automated analysis can identify “close calls” where the patient changes the therapy at the last moment, “difficulties” where the patient deviates significantly from an optimum path or “errors” where the patient initiates a therapy or setting that does not match the instructions of a trainer or caregiver. The analysis software may provide an indication of trending, that is, an evaluation of how well the patient is interacting with the user interface. It would be expected that patient performance in terms of errors would improve most greatly during an initial period and then would stabilize over time. If the system detects that the patient is regressing, such as an increase in observed errors, then the system may provide a notification of patient difficulty or regression. Other pertinent issues can readily be identified by the analysis software and are known to those of skill in the art. In step 512, the results of the analysis are used by the trainer, patient, clinician, caregiver or the like, to improve the user-device interaction. For example, improvement may be achieved by changing settings in the device, and/or providing additional training to the user.
The benefits of the parameter detecting and memory writing features during operation should be readily apparent as compared to a conventional training mode of operation. In a training mode, the device may not be coupled to the patient, or if coupled, may not be operational, and thus the user interaction scenarios are simulated and are likely not representative of that particular user's responses in a medicament delivery context. Complications can arise with medicament delivery devices such as insulin pumps because each individual user or patient responds uniquely to a given insulin dosage and rate of dosage. Additionally, each patient has a unique lifestyle, which may not be considered in the training mode. For instance, some patients have the ability to self-manage their dependency on insulin such as sensing when blood sugar is low and eating particular foods with carbohydrate levels and types adequate to safely increase their blood sugar levels. In such a scenario, the insulin delivery device may initiate therapy when it is not required, hence risking over-medication of the patient. Conversely, other patients may require significant dependence on insulin because of poor eating habits or the lack of the ability to self-manage their disease. In these scenarios the insulin delivery device may deliver too little insulin too late, thus risking under-medication of the patient.
Therefore the parameter detecting and memory writing features of operation described herein provide an individualized “fine tuning” or customization of the relationship between a patient and their device. This kind of fine tuning typically requires extensive support from trainers, clinicians, and/or other caregivers to interact with the patient on a frequent basis. However, with the ability of the device to capture user interactions along with the device parameters, the trainer, clinician and/or other caregiver can expediently identify and analyze only the relevant areas for improvement. Further, with automated analysis software, the trainer, clinician, and/or other caregiver can even more expediently identify the areas of concern and efficiently fine tune those particular areas of the user interaction. Thus, this method can effectively train patients, each with their unique circumstances and individualized response to therapy, how to efficaciously operate ambulatory medical devices while requiring reduced support from clinicians.
Although the aforementioned description specifically describes a portable medical device for administering insulin to a patient, it should be understood that such a device is only one embodiment of the invention. The device can also include any portable device having a display and a processor. For example, the device can include a mobile computing device, such as a Smartphone. In one embodiment, such a mobile computing device can function as a remote control for a portable medical device as described herein. Alternatively, a dedicated remote control specifically designed for use with a portable medical device can be used to control the device.
The methods, systems, and devices discussed above are intended merely to be examples. Various embodiments may omit, substitute, or add various procedures or components as appropriate. For example, it should be appreciated that, in alternative embodiments, the methods may be performed in an order different from that described, and various steps may be added, omitted, or combined. Also, features described with respect to certain embodiments may be combined in various other embodiments. Different aspects and elements of the embodiments may be combined in a similar manner. Also, it should be emphasized that technology evolves and, thus, many of the elements are examples and should not be interpreted to limit the scope of the invention.
Specific details are given in this description to provide a thorough understanding of the embodiments. Nevertheless, it will be understood by one of ordinary skill in the art that the embodiments may be practiced without these specific details. For example, well-known circuits, processes, algorithms, structures, and techniques have been shown without unnecessary detail in order to avoid obscuring the embodiments. Further, the headings provided herein are intended merely to aid in the clarity of the descriptions of various embodiments, and should not be construed as limiting the scope of the invention or the functionality of any part of the invention. For example, certain methods or components may be implemented as part of other methods or components, even though they are described under different headings.
It is noted that embodiments may have been described as a process that is depicted as a flow diagram or block diagram. Although each diagram may describe the process as a sequential series of operations, many of the operations can be performed in parallel or concurrently. In addition, the order of the operations may be rearranged. A process may have additional steps not included in the figures. Each operation of a process is performed or executed by the processor of the device.
The description above has been provided in terms of presently preferred embodiments so that an understanding of the present invention can be conveyed. There are, however, many configurations and techniques for data management systems that were not specifically described herein, but with which the present invention is applicable. The present invention should therefore not be seen as limited to the particular embodiments described herein, but rather, it should be understood that the present invention has wide applicability with respect to data management generally. All modifications, variations, or equivalent arrangements and implementations that are within the scope of the attached claims should therefore be considered within the scope of the invention.
This application is a continuation of application Ser. No. 15/808,286 filed Nov. 9, 2017, which in turn is a continuation of application Ser. No. 14/992,709 filed Jan. 11, 2016, now U.S. Pat. No. 9,814,835 issued Nov. 14, 2017, which in turn is a continuation of application Ser. No. 13/828,958 filed Mar. 14, 2013, now U.S. Pat. No. 9,238,100 issued Jan. 19, 2016, which claims the benefit of U.S. Provisional Application No. 61/656,984 filed Jun. 7, 2012, each of which is incorporated herein in its entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
80576 | Yu et al. | Aug 1868 | A |
2462596 | Bent | Feb 1949 | A |
2629376 | Pierre et al. | Feb 1953 | A |
2691542 | Chenoweth | Oct 1954 | A |
3059639 | Blackman et al. | Oct 1962 | A |
3189125 | Windsor et al. | Jun 1965 | A |
3227311 | Rowell | Jan 1966 | A |
3847178 | Keppel | Nov 1974 | A |
4392849 | Petre et al. | Jul 1983 | A |
4393365 | Kondo et al. | Jul 1983 | A |
4475901 | Kraegen et al. | Oct 1984 | A |
4492339 | Kreitzberg | Jan 1985 | A |
4529401 | Leslie et al. | Jul 1985 | A |
4741736 | Brown | May 1988 | A |
5000664 | Lawless et al. | Mar 1991 | A |
5050612 | Matsumura | Sep 1991 | A |
5122362 | Phillips et al. | Jun 1992 | A |
5131816 | Brown et al. | Jul 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5181910 | Scanlon | Jan 1993 | A |
5207666 | Idriss et al. | May 1993 | A |
5219330 | Bollish et al. | Jun 1993 | A |
5240603 | Frank et al. | Aug 1993 | A |
5247434 | Peterson et al. | Sep 1993 | A |
5311175 | Waldman | May 1994 | A |
5322626 | Frank et al. | Jun 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5356379 | Vaillancourt | Oct 1994 | A |
5364346 | Schrezenmeir | Nov 1994 | A |
5368562 | Blomquist et al. | Nov 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5389078 | Zalesky et al. | Feb 1995 | A |
5464392 | Epstein et al. | Nov 1995 | A |
5478211 | Dominiak | Dec 1995 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5485408 | Blomquist | Jan 1996 | A |
5497772 | Schulman et al. | Mar 1996 | A |
5522798 | Johnson et al. | Jun 1996 | A |
5551850 | Williamson et al. | Sep 1996 | A |
5558638 | Evers et al. | Sep 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5658252 | Johnson | Aug 1997 | A |
5660163 | Schulman et al. | Aug 1997 | A |
5665065 | Colman et al. | Sep 1997 | A |
5669877 | Blomquist | Sep 1997 | A |
5681285 | Ford et al. | Oct 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5695473 | Olsen | Dec 1997 | A |
5713856 | Eggers et al. | Feb 1998 | A |
5718562 | Lawless et al. | Feb 1998 | A |
5719761 | Gatti et al. | Feb 1998 | A |
5728396 | Peery et al. | Mar 1998 | A |
5745378 | Barker et al. | Apr 1998 | A |
5770149 | Raible | Jun 1998 | A |
5779122 | Martinelli | Jul 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5795327 | Wilson et al. | Aug 1998 | A |
5807336 | Russo et al. | Sep 1998 | A |
5810771 | Blomquist | Sep 1998 | A |
5814015 | Gargano et al. | Sep 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5823746 | Johnson | Oct 1998 | A |
5837220 | Blake et al. | Nov 1998 | A |
5863187 | Bensley et al. | Jan 1999 | A |
5876370 | Blomquist | Mar 1999 | A |
5879143 | Cote et al. | Mar 1999 | A |
5885211 | Eppstein et al. | Mar 1999 | A |
5919209 | Schouten | Jul 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5935106 | Olsen | Aug 1999 | A |
5960403 | Brown | Sep 1999 | A |
5985305 | Peery et al. | Nov 1999 | A |
6023629 | Tamada | Feb 2000 | A |
6024539 | Blomquist | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6053887 | Levitas et al. | Apr 2000 | A |
6077055 | Vilks | Jun 2000 | A |
6093172 | Funderburk et al. | Jul 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6120460 | Abreu | Sep 2000 | A |
6122536 | Sun et al. | Sep 2000 | A |
6135949 | Russo et al. | Oct 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6144869 | Berner et al. | Nov 2000 | A |
6175752 | Say et al. | Jan 2001 | B1 |
6179583 | Weston | Jan 2001 | B1 |
6198383 | Sekura et al. | Mar 2001 | B1 |
6231560 | Bui et al. | May 2001 | B1 |
6233471 | Berner et al. | May 2001 | B1 |
6241704 | Peterson et al. | Jun 2001 | B1 |
6248057 | Mavity et al. | Jun 2001 | B1 |
6248067 | Causey, III et al. | Jun 2001 | B1 |
6249717 | Nicholson et al. | Jun 2001 | B1 |
6270478 | Mern.o slashed.e | Aug 2001 | B1 |
6272364 | Kurnik | Aug 2001 | B1 |
6298254 | Tamada | Oct 2001 | B2 |
6306420 | Cheikh | Oct 2001 | B1 |
6358225 | Butterfield | Mar 2002 | B1 |
6360888 | McIvor et al. | Mar 2002 | B1 |
6368272 | Porumbescu | Apr 2002 | B1 |
6379301 | Worthington et al. | Apr 2002 | B1 |
6395292 | Peery et al. | May 2002 | B2 |
6422057 | Anderson | Jul 2002 | B1 |
6424847 | Mastrototaro et al. | Jul 2002 | B1 |
6427088 | Bowman, IV et al. | Jul 2002 | B1 |
6438408 | Mulligan et al. | Aug 2002 | B1 |
6458256 | Zhong | Oct 2002 | B1 |
6467267 | Kanazawa et al. | Oct 2002 | B2 |
6468242 | Wilson et al. | Oct 2002 | B1 |
6470234 | McGrady | Oct 2002 | B1 |
6475180 | Peterson et al. | Nov 2002 | B2 |
6475750 | Han et al. | Nov 2002 | B1 |
6505059 | Kollias et al. | Jan 2003 | B1 |
6514689 | Han et al. | Feb 2003 | B2 |
6517482 | Elden et al. | Feb 2003 | B1 |
6535714 | Melker et al. | Mar 2003 | B2 |
6539250 | Bettinger | Mar 2003 | B1 |
6544212 | Galley et al. | Apr 2003 | B2 |
6544229 | Danby et al. | Apr 2003 | B1 |
6546269 | Kurnik | Apr 2003 | B1 |
6551276 | Mann et al. | Apr 2003 | B1 |
6553244 | Lesho et al. | Apr 2003 | B2 |
6554798 | Mann et al. | Apr 2003 | B1 |
6558320 | Causey, III et al. | May 2003 | B1 |
6558351 | Steil et al. | May 2003 | B1 |
6558902 | Hillenkamp | May 2003 | B1 |
6562001 | Lebel et al. | May 2003 | B2 |
6564104 | Nelson et al. | May 2003 | B2 |
6565509 | Say et al. | May 2003 | B1 |
6571128 | Lebel et al. | May 2003 | B2 |
6577899 | Lebel et al. | Jun 2003 | B2 |
6582366 | Porumbescu | Jun 2003 | B1 |
6587705 | Kim et al. | Jul 2003 | B1 |
6589229 | Connelly et al. | Jul 2003 | B1 |
6594514 | Berner et al. | Jul 2003 | B2 |
6595919 | Berner et al. | Jul 2003 | B2 |
6623698 | Kuo | Sep 2003 | B2 |
6635014 | Starkweather et al. | Oct 2003 | B2 |
6641533 | Causey, III et al. | Nov 2003 | B2 |
6648821 | Lebel et al. | Nov 2003 | B2 |
6650951 | Jones et al. | Nov 2003 | B1 |
6653091 | Dunn et al. | Nov 2003 | B1 |
6656114 | Poulsen et al. | Dec 2003 | B1 |
6656158 | Mahoney et al. | Dec 2003 | B2 |
6656159 | Flaherty | Dec 2003 | B2 |
6659978 | Kasuga et al. | Dec 2003 | B1 |
6666665 | Nguyen et al. | Dec 2003 | B1 |
6668196 | Villegas et al. | Dec 2003 | B1 |
6669669 | Flaherty et al. | Dec 2003 | B2 |
6687522 | Tamada | Feb 2004 | B2 |
6692457 | Flaherty | Feb 2004 | B2 |
6694191 | Starkweather et al. | Feb 2004 | B2 |
6699218 | Flaherty et al. | Mar 2004 | B2 |
6723072 | Flaherty et al. | Apr 2004 | B2 |
6740059 | Flaherty | May 2004 | B2 |
6740072 | Starkweather et al. | May 2004 | B2 |
6740075 | Lebel et al. | May 2004 | B2 |
6744152 | Kroll | Jun 2004 | B2 |
6744350 | Blomquist | Jun 2004 | B2 |
6749587 | Flaherty | Jun 2004 | B2 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6771250 | Oh | Aug 2004 | B1 |
6773412 | O'Mahony et al. | Aug 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6796956 | Hartlaub et al. | Sep 2004 | B2 |
6801420 | Talbot et al. | Oct 2004 | B2 |
6805687 | Dextradeur et al. | Oct 2004 | B2 |
6809563 | Schaal | Oct 2004 | B2 |
6809653 | Mann et al. | Oct 2004 | B1 |
6810290 | Lebel et al. | Oct 2004 | B2 |
6821249 | Casscells, III et al. | Nov 2004 | B2 |
6830558 | Flaherty et al. | Dec 2004 | B2 |
6835175 | Porumbescu | Dec 2004 | B1 |
6850252 | Hoffberg | Feb 2005 | B1 |
6852104 | Blomquist | Feb 2005 | B2 |
6872200 | Mann et al. | Mar 2005 | B2 |
6873268 | Lebel et al. | Mar 2005 | B2 |
6880564 | Erickson | Apr 2005 | B2 |
6882940 | Potts et al. | Apr 2005 | B2 |
6886556 | Fuchs | May 2005 | B2 |
6895263 | Shin et al. | May 2005 | B2 |
6902905 | Burson et al. | Jun 2005 | B2 |
6928338 | Buchser et al. | Aug 2005 | B1 |
6934220 | Cruitt et al. | Aug 2005 | B1 |
6936029 | Mann et al. | Aug 2005 | B2 |
6949081 | Chance | Sep 2005 | B1 |
6950708 | Bowman, IV et al. | Sep 2005 | B2 |
6953323 | Childers et al. | Oct 2005 | B2 |
6957655 | Erickson et al. | Oct 2005 | B2 |
6958705 | Lebel et al. | Oct 2005 | B2 |
6960192 | Flaherty et al. | Nov 2005 | B1 |
6966325 | Erickson | Nov 2005 | B2 |
6970742 | Mann et al. | Nov 2005 | B2 |
6974437 | Lebel et al. | Dec 2005 | B2 |
6979326 | Mann et al. | Dec 2005 | B2 |
6997920 | Mann et al. | Feb 2006 | B2 |
6998387 | Goke et al. | Feb 2006 | B1 |
6999810 | Berner et al. | Feb 2006 | B2 |
6999854 | Roth | Feb 2006 | B2 |
7004928 | Aceti et al. | Feb 2006 | B2 |
7008413 | Kovach et al. | Mar 2006 | B2 |
7011630 | Desai et al. | Mar 2006 | B2 |
7015782 | Kincaid et al. | Mar 2006 | B2 |
7018360 | Flaherty et al. | Mar 2006 | B2 |
7025743 | Mann et al. | Apr 2006 | B2 |
7029455 | Flaherty | Apr 2006 | B2 |
7031772 | Condie et al. | Apr 2006 | B2 |
7033338 | Vilks et al. | Apr 2006 | B2 |
7041082 | Blomquist et al. | May 2006 | B2 |
7053761 | Schofield et al. | May 2006 | B2 |
7056179 | Courtney | Jun 2006 | B2 |
7092796 | Vanderveen | Aug 2006 | B2 |
7098803 | Mann et al. | Aug 2006 | B2 |
7107706 | Bailey, Sr. et al. | Sep 2006 | B1 |
7109878 | Mann et al. | Sep 2006 | B2 |
7128727 | Flaherty et al. | Oct 2006 | B2 |
7137964 | Flaherty | Nov 2006 | B2 |
7144384 | Gorman et al. | Dec 2006 | B2 |
7150741 | Erickson et al. | Dec 2006 | B2 |
7174199 | Berner et al. | Feb 2007 | B2 |
7179226 | Crothall et al. | Feb 2007 | B2 |
7181505 | Haller et al. | Feb 2007 | B2 |
7183068 | Burson et al. | Feb 2007 | B2 |
7187528 | Talbot et al. | Mar 2007 | B2 |
7193521 | Moberg et al. | Mar 2007 | B2 |
7204823 | Estes et al. | Apr 2007 | B2 |
7229288 | Stuart et al. | Jun 2007 | B2 |
7231263 | Choi | Jun 2007 | B2 |
7232435 | Hildebrand et al. | Jun 2007 | B2 |
7247702 | Gardner et al. | Jul 2007 | B2 |
7264730 | Connell et al. | Sep 2007 | B2 |
7267665 | Steil et al. | Sep 2007 | B2 |
7278983 | Ireland et al. | Oct 2007 | B2 |
7282029 | Poulsen et al. | Oct 2007 | B1 |
7291107 | Hellwig et al. | Nov 2007 | B2 |
7295867 | Berner et al. | Nov 2007 | B2 |
7303549 | Flaherty et al. | Dec 2007 | B2 |
7303680 | Connell et al. | Dec 2007 | B2 |
7307245 | Faries, Jr. et al. | Dec 2007 | B2 |
7318892 | Connell et al. | Jan 2008 | B2 |
7324012 | Mann et al. | Jan 2008 | B2 |
7341577 | Gill | Mar 2008 | B2 |
7351340 | Connell et al. | Apr 2008 | B2 |
7354420 | Steil et al. | Apr 2008 | B2 |
7384410 | Eggers et al. | Jun 2008 | B2 |
7385443 | Denison | Jun 2008 | B1 |
7390311 | Hildebrand et al. | Jun 2008 | B2 |
7390458 | Burow et al. | Jun 2008 | B2 |
7399277 | Saidara et al. | Jul 2008 | B2 |
7402153 | Steil et al. | Jul 2008 | B2 |
7404796 | Ginsberg | Jul 2008 | B2 |
7405055 | Dunn et al. | Jul 2008 | B2 |
7445616 | Petrakis | Nov 2008 | B2 |
7446091 | Van Den Berghe | Nov 2008 | B2 |
7460350 | Talbot et al. | Dec 2008 | B2 |
7465375 | Demers et al. | Dec 2008 | B2 |
7469383 | Busch | Dec 2008 | B2 |
7471994 | Ford et al. | Dec 2008 | B2 |
7483743 | Mann et al. | Jan 2009 | B2 |
7491187 | Van Den Berghe et al. | Feb 2009 | B2 |
7497827 | Brister et al. | Mar 2009 | B2 |
7514075 | Hedrick et al. | Apr 2009 | B2 |
7515060 | Blomquist | Apr 2009 | B2 |
7524287 | Bharmi | Apr 2009 | B2 |
7553281 | Hellwig et al. | Jun 2009 | B2 |
7556613 | Wittmann et al. | Jul 2009 | B2 |
7559926 | Blischak | Jul 2009 | B1 |
7588046 | Erickson | Sep 2009 | B1 |
7590443 | Bharmi | Sep 2009 | B2 |
7591801 | Brauker et al. | Sep 2009 | B2 |
7594889 | St. Ores et al. | Sep 2009 | B2 |
7602310 | Mann et al. | Oct 2009 | B2 |
7621893 | Moberg et al. | Nov 2009 | B2 |
7647237 | Malave et al. | Jan 2010 | B2 |
7651489 | Estes et al. | Jan 2010 | B2 |
7651845 | Doyle, III et al. | Jan 2010 | B2 |
7668731 | Martucci et al. | Feb 2010 | B2 |
7674485 | Bhaskaran et al. | Mar 2010 | B2 |
7678071 | Lebel et al. | Mar 2010 | B2 |
7678762 | Green et al. | Mar 2010 | B2 |
7678763 | Green et al. | Mar 2010 | B2 |
7687272 | Buchwald et al. | Mar 2010 | B1 |
7699775 | Desai et al. | Apr 2010 | B2 |
7704226 | Mueller, Jr. et al. | Apr 2010 | B2 |
7711402 | Shults et al. | May 2010 | B2 |
7714757 | Denison et al. | May 2010 | B2 |
7715893 | Kamath et al. | May 2010 | B2 |
7715917 | Chinchoy et al. | May 2010 | B2 |
7717903 | Estes et al. | May 2010 | B2 |
7734323 | Blomquist et al. | Jun 2010 | B2 |
7751907 | Blomquist | Jul 2010 | B2 |
7766829 | Sloan et al. | Aug 2010 | B2 |
7766873 | Moberg et al. | Aug 2010 | B2 |
7768386 | Hayter et al. | Aug 2010 | B2 |
7768408 | Reggiardo et al. | Aug 2010 | B2 |
7774038 | Wang et al. | Aug 2010 | B2 |
7774145 | Brauker et al. | Aug 2010 | B2 |
7776031 | Hartlaub et al. | Aug 2010 | B2 |
7785313 | Mastrototaro | Aug 2010 | B2 |
7801582 | Peyser | Sep 2010 | B2 |
7806853 | Wittmann et al. | Oct 2010 | B2 |
7806886 | Kanderian, Jr. et al. | Oct 2010 | B2 |
7811279 | John | Oct 2010 | B2 |
7815602 | Mann et al. | Oct 2010 | B2 |
7819843 | Mann et al. | Oct 2010 | B2 |
7831310 | Lebel et al. | Nov 2010 | B2 |
7837647 | Estes et al. | Nov 2010 | B2 |
7860583 | Condurso et al. | Dec 2010 | B2 |
7869851 | Hellwig et al. | Jan 2011 | B2 |
7875022 | Wenger et al. | Jan 2011 | B2 |
7879026 | Estes et al. | Feb 2011 | B2 |
7884729 | Reggiardo et al. | Feb 2011 | B2 |
7887505 | Flaherty | Feb 2011 | B2 |
7890295 | Shin et al. | Feb 2011 | B2 |
7892206 | Moberg et al. | Feb 2011 | B2 |
7896704 | Stafford et al. | Mar 2011 | B2 |
7912674 | Killoren Clark et al. | Mar 2011 | B2 |
7914499 | Gonnelli et al. | Mar 2011 | B2 |
7920907 | McGarraugh et al. | Apr 2011 | B2 |
7922458 | Rush et al. | Apr 2011 | B2 |
7922899 | Vasta et al. | Apr 2011 | B2 |
7935076 | Estes et al. | May 2011 | B2 |
7935104 | Yodfat et al. | May 2011 | B2 |
7935499 | Dunn et al. | May 2011 | B2 |
7938792 | Roger et al. | May 2011 | B2 |
7938797 | Estes | May 2011 | B2 |
7941200 | Weinert et al. | May 2011 | B2 |
7942844 | Moberg et al. | May 2011 | B2 |
7946985 | Mastrototaro et al. | May 2011 | B2 |
7955295 | Lee et al. | Jun 2011 | B2 |
7959598 | Estes | Jun 2011 | B2 |
7963946 | Moubayed et al. | Jun 2011 | B2 |
7967773 | Amborn et al. | Jun 2011 | B2 |
7972296 | Braig et al. | Jul 2011 | B2 |
7976492 | Brauker et al. | Jul 2011 | B2 |
7979136 | Young et al. | Jul 2011 | B2 |
7981034 | Jennewine et al. | Jul 2011 | B2 |
7985330 | Wang et al. | Jul 2011 | B2 |
7988660 | Byland et al. | Aug 2011 | B2 |
7988849 | Biewer et al. | Aug 2011 | B2 |
7988850 | Roncadi et al. | Aug 2011 | B2 |
7991625 | Rosenfeld et al. | Aug 2011 | B2 |
7991627 | Hutchinson et al. | Aug 2011 | B2 |
7993108 | Rush et al. | Aug 2011 | B2 |
7996158 | Hayter et al. | Aug 2011 | B2 |
7998111 | Moberg et al. | Aug 2011 | B2 |
7999674 | Kamen | Aug 2011 | B2 |
8005524 | Brauker et al. | Aug 2011 | B2 |
8012119 | Estes et al. | Sep 2011 | B2 |
8025634 | Moubayed et al. | Sep 2011 | B1 |
8029245 | Rush et al. | Oct 2011 | B2 |
8029250 | Rush et al. | Oct 2011 | B2 |
8029459 | Rush et al. | Oct 2011 | B2 |
8029460 | Rush et al. | Oct 2011 | B2 |
8030891 | Welsch et al. | Oct 2011 | B2 |
8032226 | Miller et al. | Oct 2011 | B2 |
8034026 | Grant et al. | Oct 2011 | B2 |
8047811 | Rush et al. | Nov 2011 | B2 |
8047812 | Rush et al. | Nov 2011 | B2 |
8060185 | Hunter et al. | Nov 2011 | B2 |
8062249 | Wilinska et al. | Nov 2011 | B2 |
8062257 | Moberg et al. | Nov 2011 | B2 |
8062513 | Yu et al. | Nov 2011 | B2 |
8065096 | Moberg et al. | Nov 2011 | B2 |
8066665 | Rush et al. | Nov 2011 | B2 |
8070742 | Woo | Dec 2011 | B2 |
8075527 | Rush et al. | Dec 2011 | B2 |
8079983 | Rush et al. | Dec 2011 | B2 |
8079984 | Rush et al. | Dec 2011 | B2 |
8083718 | Rush et al. | Dec 2011 | B2 |
8088098 | Yodfat et al. | Jan 2012 | B2 |
8090435 | Gill et al. | Jan 2012 | B2 |
8093212 | Gardner et al. | Jan 2012 | B2 |
8109893 | Lande | Feb 2012 | B2 |
8109921 | Estes et al. | Feb 2012 | B2 |
8114350 | Silver et al. | Feb 2012 | B1 |
8118770 | Galley et al. | Feb 2012 | B2 |
8119593 | Richardson et al. | Feb 2012 | B2 |
8123717 | Weinert et al. | Feb 2012 | B2 |
8127046 | Grant et al. | Feb 2012 | B2 |
8129429 | Sporn et al. | Mar 2012 | B2 |
8140312 | Hayter et al. | Mar 2012 | B2 |
8140356 | Dicks et al. | Mar 2012 | B2 |
8147446 | Yodfat et al. | Apr 2012 | B2 |
8147451 | Brockman et al. | Apr 2012 | B2 |
8152789 | Starkweather et al. | Apr 2012 | B2 |
8170721 | Nickerson | May 2012 | B2 |
8182445 | Moubayed et al. | May 2012 | B2 |
8182447 | Moberg et al. | May 2012 | B2 |
8192394 | Estes et al. | Jun 2012 | B2 |
8192395 | Estes et al. | Jun 2012 | B2 |
8202267 | Field et al. | Jun 2012 | B2 |
8204729 | Sher | Jun 2012 | B2 |
8206296 | Jennewine | Jun 2012 | B2 |
8206350 | Mann et al. | Jun 2012 | B2 |
8208984 | Blomquist et al. | Jun 2012 | B2 |
8219222 | Blomquist | Jul 2012 | B2 |
8221345 | Blomquist | Jul 2012 | B2 |
8226891 | Sloan et al. | Jul 2012 | B2 |
8231562 | Buck et al. | Jul 2012 | B2 |
8231578 | Fathallah et al. | Jul 2012 | B2 |
8234126 | Estes | Jul 2012 | B1 |
8234128 | Martucci et al. | Jul 2012 | B2 |
8236242 | Drucker et al. | Aug 2012 | B2 |
8237715 | Buck et al. | Aug 2012 | B2 |
8246540 | Ginsberg | Aug 2012 | B2 |
8249683 | Wang et al. | Aug 2012 | B2 |
8249894 | Brown | Aug 2012 | B2 |
8250483 | Blomquist | Aug 2012 | B2 |
8251904 | Zivitz et al. | Aug 2012 | B2 |
8251906 | Brauker et al. | Aug 2012 | B2 |
8257259 | Brauker et al. | Sep 2012 | B2 |
8257300 | Budiman et al. | Sep 2012 | B2 |
8260630 | Brown | Sep 2012 | B2 |
8262617 | Aeschlimann et al. | Sep 2012 | B2 |
8267892 | Spencer et al. | Sep 2012 | B2 |
8267893 | Moberg et al. | Sep 2012 | B2 |
8275438 | Simpson | Sep 2012 | B2 |
8277435 | Estes | Oct 2012 | B2 |
8285328 | Caffey et al. | Oct 2012 | B2 |
8287454 | Wolpert et al. | Oct 2012 | B2 |
8287495 | Michaud et al. | Oct 2012 | B2 |
8287514 | Miller et al. | Oct 2012 | B2 |
8294581 | Kamen | Oct 2012 | B2 |
8298184 | DiPerna et al. | Oct 2012 | B2 |
8311749 | Brauker et al. | Nov 2012 | B2 |
8313433 | Cohen et al. | Nov 2012 | B2 |
8321366 | West et al. | Nov 2012 | B2 |
8328754 | Estes et al. | Dec 2012 | B2 |
8328793 | Birkenbach et al. | Dec 2012 | B2 |
8340792 | Condurso et al. | Dec 2012 | B2 |
8343092 | Rush et al. | Jan 2013 | B2 |
8344847 | Moberg et al. | Jan 2013 | B2 |
8346399 | Blomquist | Jan 2013 | B2 |
8348885 | Moberg et al. | Jan 2013 | B2 |
8348886 | Kanderian, Jr. et al. | Jan 2013 | B2 |
8348923 | Kanderian, Jr. et al. | Jan 2013 | B2 |
8372040 | Huang et al. | Feb 2013 | B2 |
8376943 | Kovach et al. | Feb 2013 | B2 |
8385972 | Bochenko et al. | Feb 2013 | B2 |
8401194 | Nierzwick et al. | Mar 2013 | B2 |
8402151 | Young et al. | Mar 2013 | B2 |
8414523 | Blomquist et al. | Apr 2013 | B2 |
8451230 | Celentano et al. | May 2013 | B2 |
8452413 | Young et al. | May 2013 | B2 |
8452953 | Buck et al. | May 2013 | B2 |
8454510 | Yodfat et al. | Jun 2013 | B2 |
8454554 | Reinke | Jun 2013 | B2 |
8454576 | Mastrototaro et al. | Jun 2013 | B2 |
8454581 | Estes et al. | Jun 2013 | B2 |
8457901 | Beshan et al. | Jun 2013 | B2 |
8460231 | Brauker et al. | Jun 2013 | B2 |
8465460 | Yodfat et al. | Jun 2013 | B2 |
8469933 | Zhang et al. | Jun 2013 | B2 |
8533475 | Frikart et al. | Sep 2013 | B2 |
8552880 | Kopp et al. | Oct 2013 | B2 |
8562558 | Kamath et al. | Oct 2013 | B2 |
8573027 | Rosinko et al. | Nov 2013 | B2 |
8579853 | Reggiardo et al. | Nov 2013 | B2 |
8601465 | Bernstein et al. | Dec 2013 | B2 |
8650937 | Brown | Feb 2014 | B2 |
8657779 | Blomquist | Feb 2014 | B2 |
8712748 | Thukral et al. | Apr 2014 | B2 |
8718949 | Blomquist et al. | May 2014 | B2 |
8775877 | Mcvey et al. | Jul 2014 | B2 |
8801657 | Blomquist et al. | Aug 2014 | B2 |
8882701 | DeBelser et al. | Nov 2014 | B2 |
8929823 | Mears et al. | Jan 2015 | B2 |
8938306 | Lebel et al. | Jan 2015 | B2 |
8986253 | DiPerna | Mar 2015 | B2 |
9008803 | Blomquist | Apr 2015 | B2 |
9037254 | John | May 2015 | B2 |
9238100 | Kruse et al. | Jan 2016 | B2 |
9335910 | Farnan et al. | May 2016 | B2 |
9364679 | John | Jun 2016 | B2 |
9381297 | Brown | Jul 2016 | B2 |
9486171 | Saint | Nov 2016 | B2 |
9492608 | Saint | Nov 2016 | B2 |
9669160 | Harris et al. | Jun 2017 | B2 |
9715327 | Rosinko et al. | Jul 2017 | B2 |
9814835 | Kruse et al. | Nov 2017 | B2 |
9833177 | Blomquist | Dec 2017 | B2 |
9867937 | Saint et al. | Jan 2018 | B2 |
9867953 | Rosinko | Jan 2018 | B2 |
9980140 | Spencer et al. | May 2018 | B1 |
10016561 | Saint et al. | Jul 2018 | B2 |
10052049 | Blomquist et al. | Aug 2018 | B2 |
10213547 | Rosinko | Feb 2019 | B2 |
10357606 | Rosinko et al. | Jul 2019 | B2 |
10357607 | Blomquist et al. | Jul 2019 | B2 |
10549051 | Rosinko | Feb 2020 | B2 |
10569016 | Rosinko | Feb 2020 | B2 |
10653834 | Kruse et al. | May 2020 | B2 |
10864322 | Saint et al. | Dec 2020 | B2 |
10943687 | Blomquist | Mar 2021 | B2 |
20010001144 | Kapp | May 2001 | A1 |
20010031944 | Peterson et al. | Oct 2001 | A1 |
20010037217 | Abensour et al. | Nov 2001 | A1 |
20010041831 | Starkweather et al. | Nov 2001 | A1 |
20020002326 | Causey, III et al. | Jan 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020019606 | Lebel et al. | Feb 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020065454 | Lebel et al. | May 2002 | A1 |
20020072733 | Flaherty | Jun 2002 | A1 |
20020072932 | Swamy | Jun 2002 | A1 |
20020076679 | Aman | Jun 2002 | A1 |
20020077852 | Ford et al. | Jun 2002 | A1 |
20020107476 | Mann et al. | Aug 2002 | A1 |
20020117214 | Tucker et al. | Aug 2002 | A1 |
20020126036 | Flaherty | Sep 2002 | A1 |
20020143290 | Bui | Oct 2002 | A1 |
20020143580 | Bristol et al. | Oct 2002 | A1 |
20020183693 | Peterson et al. | Dec 2002 | A1 |
20020193679 | Malave et al. | Dec 2002 | A1 |
20030032867 | Crothall et al. | Feb 2003 | A1 |
20030036683 | Kehr et al. | Feb 2003 | A1 |
20030050621 | Lebel et al. | Mar 2003 | A1 |
20030055380 | Flaherty | Mar 2003 | A1 |
20030060765 | Campbell et al. | Mar 2003 | A1 |
20030065308 | Lebel et al. | Apr 2003 | A1 |
20030088238 | Poulsen et al. | May 2003 | A1 |
20030104982 | Wittmann et al. | Jun 2003 | A1 |
20030114836 | Estes et al. | Jun 2003 | A1 |
20030130616 | Steil et al. | Jul 2003 | A1 |
20030145854 | Hickle | Aug 2003 | A1 |
20030159945 | Miyazaki et al. | Aug 2003 | A1 |
20030160683 | Blomquist | Aug 2003 | A1 |
20030161744 | Vilks et al. | Aug 2003 | A1 |
20030163088 | Blomquist | Aug 2003 | A1 |
20030163090 | Blomquist et al. | Aug 2003 | A1 |
20030163223 | Blomquist | Aug 2003 | A1 |
20030163789 | Blomquist | Aug 2003 | A1 |
20030199854 | Kovach et al. | Oct 2003 | A1 |
20030208113 | Mault et al. | Nov 2003 | A1 |
20030212364 | Mann et al. | Nov 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20030236489 | Jacobson et al. | Dec 2003 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040015102 | Cummings et al. | Jan 2004 | A1 |
20040015132 | Brown | Jan 2004 | A1 |
20040054263 | Moerman et al. | Mar 2004 | A1 |
20040068230 | Estes et al. | Apr 2004 | A1 |
20040073095 | Causey, III et al. | Apr 2004 | A1 |
20040078028 | Flaherty et al. | Apr 2004 | A1 |
20040092865 | Flaherty et al. | May 2004 | A1 |
20040100507 | Hayner et al. | May 2004 | A1 |
20040115067 | Rush et al. | Jun 2004 | A1 |
20040116866 | Gorman et al. | Jun 2004 | A1 |
20040122353 | Shahmirian et al. | Jun 2004 | A1 |
20040152622 | Keith et al. | Aug 2004 | A1 |
20040180810 | Pilarski | Sep 2004 | A1 |
20040193025 | Steil et al. | Sep 2004 | A1 |
20040193090 | Lebel et al. | Sep 2004 | A1 |
20040204673 | Flaherty | Oct 2004 | A1 |
20040220551 | Flaherty et al. | Nov 2004 | A1 |
20040225252 | Gillespie et al. | Nov 2004 | A1 |
20040235446 | Flaherty et al. | Nov 2004 | A1 |
20040254434 | Goodnow et al. | Dec 2004 | A1 |
20040260233 | Garibotto et al. | Dec 2004 | A1 |
20050021006 | Tonnies | Jan 2005 | A1 |
20050022274 | Campbell et al. | Jan 2005 | A1 |
20050027182 | Siddiqui et al. | Feb 2005 | A1 |
20050030164 | Blomquist | Feb 2005 | A1 |
20050049179 | Davidson et al. | Mar 2005 | A1 |
20050050621 | Thomas | Mar 2005 | A1 |
20050065464 | Talbot et al. | Mar 2005 | A1 |
20050065760 | Murtfeldt et al. | Mar 2005 | A1 |
20050081847 | Lee et al. | Apr 2005 | A1 |
20050095063 | Fathallah et al. | May 2005 | A1 |
20050137530 | Campbell et al. | Jun 2005 | A1 |
20050143864 | Blomquist | Jun 2005 | A1 |
20050171512 | Flaherty | Aug 2005 | A1 |
20050171513 | Mann et al. | Aug 2005 | A1 |
20050177135 | Hildebrand | Aug 2005 | A1 |
20050182358 | Veit et al. | Aug 2005 | A1 |
20050192557 | Brauker et al. | Sep 2005 | A1 |
20050197553 | Cooper | Sep 2005 | A1 |
20050197621 | Poulsen et al. | Sep 2005 | A1 |
20050203349 | Nanikashvili | Sep 2005 | A1 |
20050203360 | Brauker et al. | Sep 2005 | A1 |
20050228234 | Yang | Oct 2005 | A1 |
20050238507 | Diianni et al. | Oct 2005 | A1 |
20050272640 | Doyle, III et al. | Dec 2005 | A1 |
20050277872 | Colby, Jr. et al. | Dec 2005 | A1 |
20050277912 | John | Dec 2005 | A1 |
20060001538 | Kraft et al. | Jan 2006 | A1 |
20060001550 | Mann et al. | Jan 2006 | A1 |
20060014670 | Green et al. | Jan 2006 | A1 |
20060031094 | Cohen et al. | Feb 2006 | A1 |
20060041229 | Garibotto et al. | Feb 2006 | A1 |
20060047192 | Hellwig et al. | Mar 2006 | A1 |
20060047538 | Condurso et al. | Mar 2006 | A1 |
20060080059 | Stupp et al. | Apr 2006 | A1 |
20060085223 | Anderson et al. | Apr 2006 | A1 |
20060094985 | Aceti et al. | May 2006 | A1 |
20060122577 | Poulsen et al. | Jun 2006 | A1 |
20060132292 | Blomquist | Jun 2006 | A1 |
20060137695 | Hellwig et al. | Jun 2006 | A1 |
20060167345 | Vespasiani | Jul 2006 | A1 |
20060173406 | Hayes et al. | Aug 2006 | A1 |
20060173444 | Choy et al. | Aug 2006 | A1 |
20060178633 | Garibotto et al. | Aug 2006 | A1 |
20060184154 | Moberg et al. | Aug 2006 | A1 |
20060202859 | Mastrototaro et al. | Sep 2006 | A1 |
20060224109 | Steil et al. | Oct 2006 | A1 |
20060253097 | Braig et al. | Nov 2006 | A1 |
20060264895 | Flanders | Nov 2006 | A1 |
20060271020 | Huang et al. | Nov 2006 | A1 |
20060272652 | Stocker et al. | Dec 2006 | A1 |
20060276771 | Galley et al. | Dec 2006 | A1 |
20060282290 | Flaherty et al. | Dec 2006 | A1 |
20070016127 | Staib et al. | Jan 2007 | A1 |
20070016449 | Cohen et al. | Jan 2007 | A1 |
20070021733 | Hansen et al. | Jan 2007 | A1 |
20070033074 | Nitzan et al. | Feb 2007 | A1 |
20070060796 | Kim | Mar 2007 | A1 |
20070060871 | Istoc et al. | Mar 2007 | A1 |
20070060874 | Nesbitt et al. | Mar 2007 | A1 |
20070066956 | Finkel | Mar 2007 | A1 |
20070083152 | Williams et al. | Apr 2007 | A1 |
20070083335 | Moerman | Apr 2007 | A1 |
20070093786 | Goldsmith et al. | Apr 2007 | A1 |
20070100222 | Mastrototaro et al. | May 2007 | A1 |
20070106135 | Sloan et al. | May 2007 | A1 |
20070112298 | Mueller, Jr. et al. | May 2007 | A1 |
20070112299 | Smit et al. | May 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070124002 | Estes et al. | May 2007 | A1 |
20070149861 | Crothall et al. | Jun 2007 | A1 |
20070149926 | Moberg et al. | Jun 2007 | A1 |
20070156033 | Causey, III et al. | Jul 2007 | A1 |
20070156457 | Brown | Jul 2007 | A1 |
20070173712 | Shah et al. | Jul 2007 | A1 |
20070179355 | Rosen | Aug 2007 | A1 |
20070203454 | Shermer et al. | Aug 2007 | A1 |
20070213657 | Jennewine et al. | Sep 2007 | A1 |
20070233051 | Hohl et al. | Oct 2007 | A1 |
20070251835 | Mehta et al. | Nov 2007 | A1 |
20070253021 | Mehta et al. | Nov 2007 | A1 |
20070253380 | Jollota et al. | Nov 2007 | A1 |
20070254593 | Jollota et al. | Nov 2007 | A1 |
20070255116 | Mehta et al. | Nov 2007 | A1 |
20070255125 | Moberg et al. | Nov 2007 | A1 |
20070255126 | Moberg et al. | Nov 2007 | A1 |
20070255250 | Moberg et al. | Nov 2007 | A1 |
20070255348 | Holtzclaw | Nov 2007 | A1 |
20070258395 | Jollota et al. | Nov 2007 | A1 |
20070287985 | Estes et al. | Dec 2007 | A1 |
20070299389 | Halbert et al. | Dec 2007 | A1 |
20080004601 | Jennewine et al. | Jan 2008 | A1 |
20080030369 | Mann et al. | Feb 2008 | A1 |
20080033357 | Mann et al. | Feb 2008 | A1 |
20080033360 | Evans et al. | Feb 2008 | A1 |
20080033361 | Evans et al. | Feb 2008 | A1 |
20080051709 | Mounce et al. | Feb 2008 | A1 |
20080051714 | Moberg et al. | Feb 2008 | A1 |
20080051716 | Stutz | Feb 2008 | A1 |
20080058773 | John | Mar 2008 | A1 |
20080065007 | Peterson et al. | Mar 2008 | A1 |
20080065016 | Peterson et al. | Mar 2008 | A1 |
20080071209 | Moubayed et al. | Mar 2008 | A1 |
20080071210 | Moubayed et al. | Mar 2008 | A1 |
20080071217 | Moubayed et al. | Mar 2008 | A1 |
20080071251 | Moubayed et al. | Mar 2008 | A1 |
20080071580 | Marcus et al. | Mar 2008 | A1 |
20080076969 | Kraft et al. | Mar 2008 | A1 |
20080082363 | Habashi | Apr 2008 | A1 |
20080097289 | Steil et al. | Apr 2008 | A1 |
20080106431 | Blomquist | May 2008 | A1 |
20080114299 | Damgaard-Sorensen et al. | May 2008 | A1 |
20080119705 | Patel et al. | May 2008 | A1 |
20080132844 | Peterson et al. | Jun 2008 | A1 |
20080139907 | Rao et al. | Jun 2008 | A1 |
20080147004 | Mann et al. | Jun 2008 | A1 |
20080147041 | Kristensen | Jun 2008 | A1 |
20080147042 | Pettis et al. | Jun 2008 | A1 |
20080147050 | Mann et al. | Jun 2008 | A1 |
20080154513 | Kovatchev et al. | Jun 2008 | A1 |
20080160492 | Campbell et al. | Jul 2008 | A1 |
20080171697 | Jacotot et al. | Jul 2008 | A1 |
20080171967 | Blomquist et al. | Jul 2008 | A1 |
20080172026 | Blomquist | Jul 2008 | A1 |
20080172027 | Blomquist | Jul 2008 | A1 |
20080172028 | Blomquist | Jul 2008 | A1 |
20080172029 | Blomquist | Jul 2008 | A1 |
20080172030 | Blomquist | Jul 2008 | A1 |
20080172031 | Blomquist | Jul 2008 | A1 |
20080177165 | Blomquist et al. | Jul 2008 | A1 |
20080183060 | Steil et al. | Jul 2008 | A1 |
20080201325 | Doniger | Aug 2008 | A1 |
20080206799 | Blomquist | Aug 2008 | A1 |
20080221523 | Moberg et al. | Sep 2008 | A1 |
20080222246 | Ebling et al. | Sep 2008 | A1 |
20080228056 | Blomquist et al. | Sep 2008 | A1 |
20080249470 | Malave et al. | Oct 2008 | A1 |
20080255438 | Saidara et al. | Oct 2008 | A1 |
20080255517 | Nair et al. | Oct 2008 | A1 |
20080269585 | Ginsberg | Oct 2008 | A1 |
20080269714 | Mastrototaro et al. | Oct 2008 | A1 |
20080269723 | Mastrototaro et al. | Oct 2008 | A1 |
20080287922 | Panduro | Nov 2008 | A1 |
20080288115 | Rusnak et al. | Nov 2008 | A1 |
20080294024 | Cosentino et al. | Nov 2008 | A1 |
20080294142 | Patel et al. | Nov 2008 | A1 |
20080294294 | Blomquist | Nov 2008 | A1 |
20080300534 | Blomquist | Dec 2008 | A1 |
20080300572 | Rankers et al. | Dec 2008 | A1 |
20080306434 | Dobbles et al. | Dec 2008 | A1 |
20080306444 | Brister et al. | Dec 2008 | A1 |
20080312585 | Brukalo et al. | Dec 2008 | A1 |
20090005726 | Jones et al. | Jan 2009 | A1 |
20090006061 | Thukral et al. | Jan 2009 | A1 |
20090018779 | Cohen et al. | Jan 2009 | A1 |
20090030733 | Cohen et al. | Jan 2009 | A1 |
20090036753 | King | Feb 2009 | A1 |
20090037020 | Brown | Feb 2009 | A1 |
20090054475 | Chen et al. | Feb 2009 | A1 |
20090062729 | Woo | Mar 2009 | A1 |
20090069745 | Estes et al. | Mar 2009 | A1 |
20090069749 | Miller et al. | Mar 2009 | A1 |
20090069784 | Estes et al. | Mar 2009 | A1 |
20090069787 | Estes et al. | Mar 2009 | A1 |
20090088731 | Campbell et al. | Apr 2009 | A1 |
20090093756 | Minaie et al. | Apr 2009 | A1 |
20090105636 | Hayter et al. | Apr 2009 | A1 |
20090105646 | Hendrixson et al. | Apr 2009 | A1 |
20090112626 | Talbot et al. | Apr 2009 | A1 |
20090131860 | Nielsen | May 2009 | A1 |
20090131861 | Braig et al. | May 2009 | A1 |
20090143661 | Taub et al. | Jun 2009 | A1 |
20090150186 | Cohen et al. | Jun 2009 | A1 |
20090150865 | Young et al. | Jun 2009 | A1 |
20090156990 | Wenger et al. | Jun 2009 | A1 |
20090157003 | Jones et al. | Jun 2009 | A1 |
20090157202 | Roberts et al. | Jun 2009 | A1 |
20090158274 | Roberts | Jun 2009 | A1 |
20090163855 | Shin et al. | Jun 2009 | A1 |
20090164239 | Hayter et al. | Jun 2009 | A1 |
20090171269 | Jennewine et al. | Jul 2009 | A1 |
20090177142 | Blomquist et al. | Jul 2009 | A1 |
20090177147 | Blomquist et al. | Jul 2009 | A1 |
20090177154 | Blomquist | Jul 2009 | A1 |
20090177180 | Rubalcaba, Jr. et al. | Jul 2009 | A1 |
20090192366 | Mensinger et al. | Jul 2009 | A1 |
20090192724 | Brauker et al. | Jul 2009 | A1 |
20090192745 | Kamath et al. | Jul 2009 | A1 |
20090212966 | Panduro | Aug 2009 | A1 |
20090216100 | Ebner et al. | Aug 2009 | A1 |
20090221890 | Saffer et al. | Sep 2009 | A1 |
20090247931 | Damgaard-Sorensen | Oct 2009 | A1 |
20090247982 | Krulevitch et al. | Oct 2009 | A1 |
20090254037 | Bryant, Jr. et al. | Oct 2009 | A1 |
20090256527 | Welsch et al. | Oct 2009 | A1 |
20090267774 | Enegren et al. | Oct 2009 | A1 |
20090267775 | Enegren et al. | Oct 2009 | A1 |
20090270705 | Enegren et al. | Oct 2009 | A1 |
20090275887 | Estes | Nov 2009 | A1 |
20090281393 | Smith | Nov 2009 | A1 |
20100008795 | DiPerna | Jan 2010 | A1 |
20100010330 | Rankers et al. | Jan 2010 | A1 |
20100022937 | Bedingfield et al. | Jan 2010 | A1 |
20100030045 | Gottlieb et al. | Feb 2010 | A1 |
20100030387 | Sen | Feb 2010 | A1 |
20100037680 | Moberg et al. | Feb 2010 | A1 |
20100056993 | Chase | Mar 2010 | A1 |
20100057043 | Kovatchev et al. | Mar 2010 | A1 |
20100064257 | Buck et al. | Mar 2010 | A1 |
20100069730 | Bergstrom et al. | Mar 2010 | A1 |
20100081993 | O'Connor | Apr 2010 | A1 |
20100094110 | Heller et al. | Apr 2010 | A1 |
20100095229 | Dixon et al. | Apr 2010 | A1 |
20100105999 | Dixon et al. | Apr 2010 | A1 |
20100114015 | Kanderian, Jr. et al. | May 2010 | A1 |
20100121169 | Petisce et al. | May 2010 | A1 |
20100121170 | Rule | May 2010 | A1 |
20100121415 | Skelton et al. | May 2010 | A1 |
20100125241 | Prud'Homme et al. | May 2010 | A1 |
20100130933 | Holland et al. | May 2010 | A1 |
20100138197 | Sher | Jun 2010 | A1 |
20100145276 | Yodfat et al. | Jun 2010 | A1 |
20100146300 | Brown | Jun 2010 | A1 |
20100160740 | Cohen et al. | Jun 2010 | A1 |
20100161236 | Cohen et al. | Jun 2010 | A1 |
20100161346 | Getschmann et al. | Jun 2010 | A1 |
20100162786 | Keenan et al. | Jul 2010 | A1 |
20100168539 | Palerm et al. | Jul 2010 | A1 |
20100174266 | Estes | Jul 2010 | A1 |
20100174553 | Kaufman et al. | Jul 2010 | A1 |
20100179402 | Goode, Jr. et al. | Jul 2010 | A1 |
20100185142 | Kamen et al. | Jul 2010 | A1 |
20100185152 | Larsen et al. | Jul 2010 | A1 |
20100185175 | Kamen et al. | Jul 2010 | A1 |
20100198142 | Sloan et al. | Aug 2010 | A1 |
20100205001 | Knudsen et al. | Aug 2010 | A1 |
20100217192 | Moberg et al. | Aug 2010 | A1 |
20100217193 | Moberg et al. | Aug 2010 | A1 |
20100218132 | Soni et al. | Aug 2010 | A1 |
20100222765 | Blomquist et al. | Sep 2010 | A1 |
20100228186 | Estes et al. | Sep 2010 | A1 |
20100248706 | Potkonjak et al. | Sep 2010 | A1 |
20100249566 | Suess et al. | Sep 2010 | A1 |
20100261987 | Kamath et al. | Oct 2010 | A1 |
20100262078 | Blomquist | Oct 2010 | A1 |
20100262117 | Magni et al. | Oct 2010 | A1 |
20100262434 | Shaya | Oct 2010 | A1 |
20100274218 | Yodfat et al. | Oct 2010 | A1 |
20100274592 | Nitzan et al. | Oct 2010 | A1 |
20100274751 | Blomquist | Oct 2010 | A1 |
20100277119 | Montague et al. | Nov 2010 | A1 |
20100280442 | Shahmirian et al. | Nov 2010 | A1 |
20100286601 | Yodfat et al. | Nov 2010 | A1 |
20100286653 | Kubel et al. | Nov 2010 | A1 |
20100292556 | Golden | Nov 2010 | A1 |
20100292634 | Kircher, Jr. et al. | Nov 2010 | A1 |
20100295686 | Sloan et al. | Nov 2010 | A1 |
20100298685 | Hayter et al. | Nov 2010 | A1 |
20100298765 | Budiman | Nov 2010 | A1 |
20100305545 | Kanderian, Jr. et al. | Dec 2010 | A1 |
20100312085 | Andrews et al. | Dec 2010 | A1 |
20100324382 | Cantwell et al. | Dec 2010 | A1 |
20100324398 | Tzyy-Ping | Dec 2010 | A1 |
20100324853 | Wang et al. | Dec 2010 | A1 |
20100331651 | Groll | Dec 2010 | A1 |
20100331652 | Groll et al. | Dec 2010 | A1 |
20110004188 | Shekalim | Jan 2011 | A1 |
20110015509 | Peyser | Jan 2011 | A1 |
20110021898 | Wei et al. | Jan 2011 | A1 |
20110033833 | Blomquist et al. | Feb 2011 | A1 |
20110034792 | Williams et al. | Feb 2011 | A1 |
20110040247 | Mandro et al. | Feb 2011 | A1 |
20110040251 | Blomquist et al. | Feb 2011 | A1 |
20110046697 | Gerber et al. | Feb 2011 | A1 |
20110047499 | Mandro et al. | Feb 2011 | A1 |
20110053121 | Heaton | Mar 2011 | A1 |
20110054390 | Searle et al. | Mar 2011 | A1 |
20110054391 | Ward et al. | Mar 2011 | A1 |
20110056264 | Kaplan et al. | Mar 2011 | A1 |
20110058485 | Sloan | Mar 2011 | A1 |
20110060281 | Aeschlimann et al. | Mar 2011 | A1 |
20110071372 | Sloan et al. | Mar 2011 | A1 |
20110071464 | Palerm | Mar 2011 | A1 |
20110071765 | Yodfat et al. | Mar 2011 | A1 |
20110077963 | Knudsen et al. | Mar 2011 | A1 |
20110082439 | Wenger et al. | Apr 2011 | A1 |
20110087165 | Amborn et al. | Apr 2011 | A1 |
20110092788 | Long et al. | Apr 2011 | A1 |
20110093286 | Dicks et al. | Apr 2011 | A1 |
20110098548 | Budiman et al. | Apr 2011 | A1 |
20110098637 | Hill | Apr 2011 | A1 |
20110098638 | Chawla et al. | Apr 2011 | A1 |
20110098674 | Vicente et al. | Apr 2011 | A1 |
20110106011 | Cinar et al. | May 2011 | A1 |
20110106050 | Yodfat et al. | May 2011 | A1 |
20110112505 | Starkweather et al. | May 2011 | A1 |
20110112506 | Starkweather et al. | May 2011 | A1 |
20110118578 | Timmerman | May 2011 | A1 |
20110118699 | Yodfat et al. | May 2011 | A1 |
20110124996 | Reinke et al. | May 2011 | A1 |
20110124999 | Reggiardo et al. | May 2011 | A1 |
20110125095 | Lebel et al. | May 2011 | A1 |
20110126188 | Bernstein et al. | May 2011 | A1 |
20110130716 | Estes et al. | Jun 2011 | A1 |
20110130746 | Budiman | Jun 2011 | A1 |
20110133946 | Kopp et al. | Jun 2011 | A1 |
20110137239 | Debelser et al. | Jun 2011 | A1 |
20110144586 | Michaud et al. | Jun 2011 | A1 |
20110144616 | Michaud et al. | Jun 2011 | A1 |
20110152770 | DiPerna et al. | Jun 2011 | A1 |
20110152824 | DiPerna et al. | Jun 2011 | A1 |
20110160650 | Chong et al. | Jun 2011 | A1 |
20110160654 | Hanson et al. | Jun 2011 | A1 |
20110160666 | Hanson et al. | Jun 2011 | A1 |
20110163881 | Halff et al. | Jul 2011 | A1 |
20110166544 | Verhoef et al. | Jul 2011 | A1 |
20110166875 | Hayter et al. | Jul 2011 | A1 |
20110178461 | Chong et al. | Jul 2011 | A1 |
20110178462 | Moberg et al. | Jul 2011 | A1 |
20110178717 | Goodnow et al. | Jul 2011 | A1 |
20110184342 | Pesach et al. | Jul 2011 | A1 |
20110190701 | Remde et al. | Aug 2011 | A1 |
20110196213 | Thukral et al. | Aug 2011 | A1 |
20110202040 | Remde et al. | Aug 2011 | A1 |
20110205065 | Strachan et al. | Aug 2011 | A1 |
20110208123 | Gray et al. | Aug 2011 | A1 |
20110208155 | Palerm et al. | Aug 2011 | A1 |
20110213306 | Hanson et al. | Sep 2011 | A1 |
20110224522 | Fennell | Sep 2011 | A1 |
20110256024 | Cole et al. | Oct 2011 | A1 |
20110257625 | Jasperson et al. | Oct 2011 | A1 |
20110257895 | Brauker et al. | Oct 2011 | A1 |
20110266999 | Yodfat et al. | Nov 2011 | A1 |
20110320595 | Konishi et al. | Dec 2011 | A1 |
20120022452 | Welsch et al. | Jan 2012 | A1 |
20120029433 | Michaud et al. | Feb 2012 | A1 |
20120029941 | Malave et al. | Feb 2012 | A1 |
20120030610 | DiPerna et al. | Feb 2012 | A1 |
20120041415 | Estes et al. | Feb 2012 | A1 |
20120053522 | Yodfat et al. | Mar 2012 | A1 |
20120059353 | Kovatchev et al. | Mar 2012 | A1 |
20120059673 | Cohen et al. | Mar 2012 | A1 |
20120095315 | Tenbarge et al. | Apr 2012 | A1 |
20120095393 | Reinke | Apr 2012 | A1 |
20120096451 | Tenbarge | Apr 2012 | A1 |
20120109100 | Estes et al. | May 2012 | A1 |
20120123230 | Brown et al. | May 2012 | A1 |
20120163481 | Ebner et al. | Jun 2012 | A1 |
20120165614 | Strickland | Jun 2012 | A1 |
20120165728 | Strickland et al. | Jun 2012 | A1 |
20120184907 | Smith | Jul 2012 | A1 |
20120185267 | Kamen et al. | Jul 2012 | A1 |
20120191061 | Yodfat et al. | Jul 2012 | A1 |
20120191063 | Brauker et al. | Jul 2012 | A1 |
20120226124 | Blomquist | Sep 2012 | A1 |
20120232484 | Blomquist | Sep 2012 | A1 |
20120232485 | Blomquist | Sep 2012 | A1 |
20120232520 | Sloan et al. | Sep 2012 | A1 |
20120232521 | Blomquist | Sep 2012 | A1 |
20120238852 | Brauker et al. | Sep 2012 | A1 |
20120238854 | Blomquist et al. | Sep 2012 | A1 |
20120239362 | Blomquist | Sep 2012 | A1 |
20120245524 | Estes et al. | Sep 2012 | A1 |
20120265722 | Blomquist | Oct 2012 | A1 |
20120296269 | Blomquist | Nov 2012 | A1 |
20120330227 | Budiman et al. | Dec 2012 | A1 |
20130012917 | Miller et al. | Jan 2013 | A1 |
20130053816 | DiPERNA et al. | Feb 2013 | A1 |
20130096953 | Beverly et al. | Apr 2013 | A1 |
20130116649 | Breton et al. | May 2013 | A1 |
20130131630 | Blomquist | May 2013 | A1 |
20130142367 | Berry et al. | Jun 2013 | A1 |
20130172710 | Mears | Jul 2013 | A1 |
20130231711 | Kaib | Sep 2013 | A1 |
20130237947 | Amirouche | Sep 2013 | A1 |
20130283196 | Farnan | Oct 2013 | A1 |
20130324928 | Kruse | Dec 2013 | A1 |
20130331790 | Brown | Dec 2013 | A1 |
20130332874 | Rosinko et al. | Dec 2013 | A1 |
20130345625 | Causey, III et al. | Dec 2013 | A1 |
20140012511 | Mensinger et al. | Jan 2014 | A1 |
20140019396 | Carlsgaard et al. | Jan 2014 | A1 |
20140039392 | Geipel et al. | Feb 2014 | A1 |
20140066890 | Sloan et al. | Mar 2014 | A1 |
20140074059 | Howell et al. | Mar 2014 | A1 |
20140100829 | Mould | Apr 2014 | A1 |
20140137641 | Brown | May 2014 | A1 |
20140171772 | Blomquist | Jun 2014 | A1 |
20140187890 | Mensinger et al. | Jul 2014 | A1 |
20140273042 | Saint | Sep 2014 | A1 |
20140275419 | Ward et al. | Sep 2014 | A1 |
20140276419 | Rosinko et al. | Sep 2014 | A1 |
20140276420 | Rosinko | Sep 2014 | A1 |
20140276531 | Walsh | Sep 2014 | A1 |
20140276553 | Rosinko et al. | Sep 2014 | A1 |
20140276556 | Saint et al. | Sep 2014 | A1 |
20140276570 | Saint | Sep 2014 | A1 |
20140276574 | Saint | Sep 2014 | A1 |
20140350371 | Blomquist et al. | Nov 2014 | A1 |
20140378898 | Rosinko | Dec 2014 | A1 |
20150073337 | Saint et al. | Mar 2015 | A1 |
20150182693 | Rosinko | Jul 2015 | A1 |
20150182695 | Rosinko | Jul 2015 | A1 |
20150217044 | Blomquist | Aug 2015 | A1 |
20150314062 | Blomquist et al. | Nov 2015 | A1 |
20160030669 | Harris et al. | Feb 2016 | A1 |
20160082188 | Blomquist et al. | Mar 2016 | A1 |
20160119210 | Koehler et al. | Apr 2016 | A1 |
20160199571 | Rosinko et al. | Jul 2016 | A1 |
20160228041 | Heller et al. | Aug 2016 | A1 |
20160256622 | Day | Sep 2016 | A1 |
20160271325 | Farnan et al. | Sep 2016 | A1 |
20170000943 | Blomquist et al. | Jan 2017 | A1 |
20170056590 | DiPerna et al. | Mar 2017 | A1 |
20170300206 | Rosinko et al. | Oct 2017 | A1 |
20180021514 | Rosinko | Jan 2018 | A1 |
20180042559 | Cabrera, Jr. | Feb 2018 | A1 |
20180071454 | Betts | Mar 2018 | A1 |
20180092578 | Blomquist | Apr 2018 | A1 |
20180137938 | Vaddiraju | May 2018 | A1 |
20180193573 | Rosinko | Jul 2018 | A1 |
20190350501 | Blomquist et al. | Nov 2019 | A1 |
20190365997 | Harris | Dec 2019 | A1 |
20190388015 | Blomquist | Dec 2019 | A1 |
20200101226 | Saint et al. | Apr 2020 | A1 |
20200114076 | Ulrich et al. | Apr 2020 | A1 |
20200171249 | Rosinko | Jun 2020 | A1 |
20200179603 | Rosinko | Jun 2020 | A1 |
20200261649 | Michaud et al. | Aug 2020 | A1 |
20200368430 | Ulrich et al. | Nov 2020 | A1 |
20210001044 | Michaud et al. | Jan 2021 | A1 |
Number | Date | Country |
---|---|---|
2930776 | May 2018 | CA |
399065 | Jul 1924 | DE |
4407005 | Mar 1995 | DE |
19819407 | Nov 1999 | DE |
10121317 | Nov 2002 | DE |
10352456 | Jul 2005 | DE |
1102194 | May 2001 | EP |
1571582 | Sep 2005 | EP |
2006034323 | Feb 2006 | JP |
WO-0045696 | Aug 2000 | WO |
WO-0074753 | Dec 2000 | WO |
WO-0152727 | Jul 2001 | WO |
WO-02062212 | Aug 2002 | WO |
WO-03082091 | Oct 2003 | WO |
WO-2004093648 | Nov 2004 | WO |
WO-2005046559 | May 2005 | WO |
WO-2006061169 | Jun 2006 | WO |
WO-2006127841 | Nov 2006 | WO |
WO-2007000425 | Jan 2007 | WO |
WO-2007056592 | May 2007 | WO |
WO-2007089537 | Aug 2007 | WO |
WO-2007149533 | Dec 2007 | WO |
WO-2008048556 | Apr 2008 | WO |
WO-2008048582 | Apr 2008 | WO |
WO-2008048583 | Apr 2008 | WO |
WO-2008048584 | Apr 2008 | WO |
WO-2008048585 | Apr 2008 | WO |
WO-2008048586 | Apr 2008 | WO |
WO-2008048587 | Apr 2008 | WO |
WO-2008091320 | Jul 2008 | WO |
WO-2008112078 | Sep 2008 | WO |
WO-2008153689 | Dec 2008 | WO |
WO-2008153819 | Dec 2008 | WO |
WO-2009016636 | Feb 2009 | WO |
WO-2009032400 | Mar 2009 | WO |
WO-2009032402 | Mar 2009 | WO |
WO-2009035759 | Mar 2009 | WO |
WO-2009088983 | Jul 2009 | WO |
WO-2009089028 | Jul 2009 | WO |
WO-2009089029 | Jul 2009 | WO |
WO-2010056663 | May 2010 | WO |
WO-2011068648 | Jun 2011 | WO |
WO-2013016363 | Jan 2013 | WO |
WO-2013184896 | Dec 2013 | WO |
Entry |
---|
US 8,333,733 B2, 12/2012, Lanigan et al. (withdrawn) |
Application and File History for U.S. Appl. No. 16/394,751, filed Apr. 25, 2019, inventors Blomquist et al. |
Application and File History for U.S. Appl. No. 13/828,958, filed Mar. 14, 2013, inventors Kruse et al. |
Application and File History for U.S. Appl. No. 15/808,286, filed Nov. 9, 2017, inventors Kruse et al. |
Application and File History for U.S. Appl. No. 14/992,709, filed Jan. 11, 2016, inventors Kruse et al. |
Bott, et al., “Impact of Smoking on the Metabolic Action of Subcutaneous Regular Insulin in Type 2 Diabetic Patients,” Horm. Metab. Res., vol. 37, 2005, pp. 445-449. |
Chase, et at., “The Use of Insulin Pumps With Meal Bolus Alarms in Children With Type 1 Diabetes to Improve Glycemic Control,” Diabetes Carem, vol. 29, No. 5, May 2006, pp. 1012-1015. |
“Compare Insulin Pump for Diabetes,” Printed from www.diabetesnet.com/diabetes-technology/insulin-pump-models.php, Jun. 18, 2009, 4 pages. |
International Preliminary Reporton Patentability for Application No. PCT/US2013/044319, dated Dec. 18, 2014, 6 pages. |
International Search Report and Written Opinion for Application No. PCT/US2013/044319, dated Nov. 6, 2013, 12 pages. |
Lehmann, et al., “Combining rule-based reasoning and mathematical modeling in diabetes care,” Artificial Intelligence in Medicine, vol. 6, 1994, pp. 137-160. |
Hildebrandt P, “Subcutaneous Absorption of Insulin in Insulin-Dependent Diavetic patients. Influence of Species Physico-Chemical properties of Insulin and Physiological factors,” Danish Medical Bulletin, Aug. 1991, 10 pages. |
Plougmann, et al.,“ DiasNet—a diabetes advisory system for communication and education via the internet,” International Journal of Medical Informatics, vol. 64, 2001, pp. 319-330. |
Puckett, et al., “A model for multiple subcutaneous insulin injections developed from individual diabetic patient data,” vol. 269, 1995, p. E1115-E1124. |
Smith Medical MD Inc., “Deltec Cozmo, Personalized Insulin Pump, Starting Guide,” http://web.archive.org/web/20041207133223/http://www.cozmore.com/Library/-upload/starting.sub.—guide.sub.—032004.pdf, XP002497833, Dec. 7, 2004, pp. 1-83. |
Stapel E., “Converting Between Decimals, Fractions, and Percents,” Purplemath, 2006, 9 pages, Available at http://www.purplemath.com/modules/percents2.htm, 2006. |
Trajanoski, et al., “Pharmacokinetic Model for the Absorption of Subcutaneously Injected Soluble Insulin and Monomeric Insulin Analogues,” Biomedizinische Technik, vol. 38, No. 9. Sep. 1, 1993, pp. 224-231. |
Wach, et al., “Numerical Approximation of Mathematical Model for Absorption of Subcutaneously Injected Insulin,” Med & Biol. Eng & comput., vol. 33, 1995, pp. 18-23. |
Walsh, et al., “Diabetes Technology-Concept 1: Super Bolus,” available at Diabetes Technology—Concept 1: Super Bolus available at http://www.diabetesnet.com/diabetes.sub.—technology/super.sub.—bolus.ph-p>, Sep. 17, 2007, 3 pages. |
Walsh J., et al., “Select & Test Your Correction Factor,” Pumping Insulin, Fourth Edition, Chapter 13, 2006, 10 Pages. |
Walsh J., et al., “Select & Test Your Basal Rates,” Pumping Insulin, Fourth Edition, Chapter 11, 2006, 30 pages. |
Walsh J., et al., “Select and Test Your Carb Factor,” Pumping Insulin, Fourth Edition, Chapter 12, 2006, 32 pages. |
Walsh J., et al., “Pumping Insulin: Everything you need for Success on a Smart insulin Pump,” Torrey Pines Press, San Diego, ISBN 1-884804-86-1, 2006, 3 pages. |
Wikipedia.com, “Wikipedia's definition for “basal rate”,” printed from wikipedia.com on Jun. 12, 2009, 1 page. |
Wilinska, et al., “Insulin Kinetics in Type-1 Diabetes: Continuous and Bolus Delivery of Rapid Acting Insulin,” IEEE Transactions on Biomedical Engineering, vol. 52, No. 1, Jan. 2005, pp. 3-12. |
Number | Date | Country | |
---|---|---|---|
20200254174 A1 | Aug 2020 | US |
Number | Date | Country | |
---|---|---|---|
61656984 | Jun 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15808286 | Nov 2017 | US |
Child | 16846908 | US | |
Parent | 14992709 | Jan 2016 | US |
Child | 15808286 | US | |
Parent | 13828958 | Mar 2013 | US |
Child | 14992709 | US |